Your browser doesn't support javascript.
loading
Analysis of SARS-CoV-2 Emergent Variants Following AZD7442 (Tixagevimab/Cilgavimab) for Early Outpatient Treatment of COVID-19 (TACKLE Trial).
Kijak, Gustavo H; Ahani, Bahar; Arbetter, Douglas; Chuecos, Fernando; Gopalakrishnan, Vancheswaran; Beloor, Jagadish; Brady, Tyler; Nguyen, Amy; Roe, Tiffany L; Schuko, Nicolette; Zhang, Tianhui; Hobbs, F D Richard; Padilla, Francisco; Kelly, Elizabeth J; Montgomery, Hugh; Streicher, Katie.
Afiliación
  • Kijak GH; Translational Medicine, Vaccines & Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA. gustavo.kijak@astrazeneca.com.
  • Ahani B; Bioinformatics, Vaccines & Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.
  • Arbetter D; Biometrics, Vaccines & Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Boston, MA, USA.
  • Chuecos F; Biometrics, Vaccines & Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Barcelona, Spain.
  • Gopalakrishnan V; Bioinformatics, Vaccines & Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.
  • Beloor J; Translational Medicine, Vaccines & Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.
  • Brady T; Translational Medicine, Vaccines & Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.
  • Nguyen A; Translational Medicine, Vaccines & Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.
  • Roe TL; Translational Medicine, Vaccines & Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.
  • Schuko N; Translational Medicine, Vaccines & Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.
  • Zhang T; Formerly Data Sciences and Quantitative Biology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.
  • Hobbs FDR; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
  • Padilla F; Centro de Investigación en Cardiología y Metabolismo, Guadalajara, Jalisco, Mexico.
  • Kelly EJ; Formerly Translational Medicine, Vaccines & Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.
  • Montgomery H; Department of Medicine, University College London, London, UK.
  • Streicher K; Translational Medicine, Vaccines & Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.
Infect Dis Ther ; 12(12): 2691-2707, 2023 Dec.
Article en En | MEDLINE | ID: mdl-37914983
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Infect Dis Ther Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Infect Dis Ther Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos